zoledronate
Meaning of zoledronate: An infusion that shuts down the cells dismantling bone, given as rarely as once a year in some conditions.
Definition of zoledronate
Zoledronate is a nitrogen-containing bisphosphonate given by drip into a vein to slow the breakdown of bone. It binds tightly to bone mineral and is then swallowed by osteoclasts, the cells that dissolve old bone, disabling them. It is used for osteoporosis, for Paget disease of bone, and in cancer for dangerously high calcium levels and for bone weakened by secondary deposits.
How does it work?
Bone is rebuilt continuously, one set of cells dissolving old bone while another lays down new. A bisphosphonate sticks to the mineral surface and waits there. When an osteoclast starts dissolving that patch, it takes the drug in, and inside the cell the drug blocks an enzyme the cell needs to hold its shape and stay attached. The cell stops working and dies early. Building carries on meanwhile, so the balance tips toward keeping bone. Drug still bound to the mineral is released only as that bone is remodeled, which is why the effect outlasts the last dose by a long way.
What is it used for?
| Setting | Purpose |
|---|---|
| Osteoporosis | Reduce fracture risk at the spine and hip |
| Paget disease of bone | Quiet disordered, overactive bone turnover |
| Hypercalcemia of malignancy | Bring a dangerously high blood calcium down |
| Bone deposits from solid tumors | Reduce fractures, bone pain and the need for radiation |
| Multiple myeloma | Protect bone that the disease is actively destroying |
Schedules differ sharply across that list. Bone protection in cancer is repeated every few weeks or months, while a single infusion covers a year or longer in osteoporosis, and the dose is not the same either.
What are the recognized problems?
A first infusion often brings an acute phase reaction: fever, aching muscles and joints, and fatigue lasting a day or two, much less pronounced with later doses. Blood calcium can fall, particularly where vitamin D is already low, so calcium status is checked beforehand. The drug is cleared by the kidney, and impaired kidney function limits its use. Two uncommon problems attach to prolonged treatment at cancer doses: exposed dead bone in the jaw, most often after a dental extraction, and an unusual fracture pattern in the thigh bone.
Also known as
Used in a sentence
Zoledronate was given by infusion for hypercalcemia related to the malignancy.
Good to know
Dose and interval differ substantially between the cancer indications and osteoporosis, and the drug stays bound to bone long after the last infusion, so its effect does not end when treatment ends.